Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Seeking Diversification Through Drug Company Dividend Stocks
Seeking Alpha
Thursday, October 6, 2011 - 12:00pm
tags:
dividends, JNJ, Pfizer, Novartis, GSK, Merck, Sanofi, Abbott Laboratories, AstraZeneca, Amgen, Eli Lilly, Bristol-Myers Squibb
Merck Announces Retirement of Chairman and Former CEO Richard T. Clark
Yahoo
Thursday, October 6, 2011 - 11:58am
tags:
Merck, Richard Clark
More Drugs Mean More Disease as China Fails to Control Use of Antibiotics
Bloomberg
Thursday, October 6, 2011 - 11:58am
tags:
China, antibiotics
Millennium withdraws cancer drug application
Bizjournals.com
Thursday, October 6, 2011 - 11:56am
tags:
Millennium, Velcade, follicular lymphoma, JNJ
ImmunoCellular Therapeutics: The Biotechnology Moneyball
Seeking Alpha
Thursday, October 6, 2011 - 9:34am
tags:
ImmunoCellular, ICT-107, GBM, glioblastoma multiforme, brain cancer
In Memory Of Steve Jobs, Novartis Pushes iPad
Pharmalot
Thursday, October 6, 2011 - 9:31am
tags:
Steve Jobs, Novartis, Apple, iPad, Joe Jimenez, drug reps
Pfizer's Selling, Not Buying, Pipeline Drugs?
Motley Fool
Thursday, October 6, 2011 - 9:29am
tags:
Pfizer, patents, tremelimumab, AstraZeneca
Merck Fine-Tunes Biosimilars Strategy as FDA Guidelines Loom
Motley Fool
Thursday, October 6, 2011 - 9:25am
tags:
biosimilars, Merck, FDA
Pfizer Stops Trial of Epilepsy Drug Lyrica as Efficacy Proved
Bloomberg
Thursday, October 6, 2011 - 9:24am
tags:
Pfizer, Lyrica, epilepsy
Brand Power To The People: J&J Takes Lead In Forbes Ranking
Forbes
Thursday, October 6, 2011 - 9:22am
tags:
JNJ, branding
Rivaroxaban Roundup: NEJM Perspective on FDA Panel, ATLAS-ACS Will Be an AHA Late-Breaker
Forbes
Thursday, October 6, 2011 - 9:18am
tags:
FDA, rivaroxaban, Xarelto, Bayer, JNJ
US Army to host pharma industry day to inform potential contractors about an available opportunity
CP Wire
Wednesday, October 5, 2011 - 1:21pm
tags:
defense contracts, army
Biotech's Burning Questions for Q3 Earnings
TheStreet.com
Wednesday, October 5, 2011 - 11:01am
tags:
earnings, biotech, Dendreon, Vertex, Human Genome Sciences
Change of heart: Why Pozen now wants to partner its cardiovascular drug
Med City
Wednesday, October 5, 2011 - 10:59am
tags:
Pozen, PA32540, AstraZeneca, GSK
J&J To Pay $48M To Man Hurt By Motrin
Pharmalot
Wednesday, October 5, 2011 - 10:57am
tags:
Motrin, JNJ, settlements
Doctors Grow Wary of Avastin for Eye Treatment
NY Times, NY
Wednesday, October 5, 2011 - 10:55am
tags:
Genentech, Avastin, Lucentis
BioCryst says gout drug worked in mid-stage trial
Yahoo/AP
Wednesday, October 5, 2011 - 10:54am
tags:
Biocryst, gout, BCX4208
Merck and Ariad say FDA will review application for their sarcoma pill ridaforolimus
Yahoo/AP
Wednesday, October 5, 2011 - 10:52am
tags:
FDA, sarcoma, ridaforolimus, Merck, Ariad Pharmaceuticals
Celgene pays Agios $20M to extend cancer drug pact
Yahoo/AP
Wednesday, October 5, 2011 - 10:51am
tags:
Celgene, Agios Pharmaceuticals, cancer
New label on Genentech's Avastin warns of infertility
Bizjournals.com
Wednesday, October 5, 2011 - 10:50am
tags:
Avastin, Infertility, warnings, Genentech

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.